Jeffrey C. Hageman*

, Timothy M. Uyeki*, John S. Francis†, Daniel B. Jernigan*, J. Gary Wheeler‡, Carolyn B. Bridges*, Stephen J. Barenkamp§, Dawn M. Sievert¶, Arjun Srinivasan*, Meg C. Doherty†, Linda K. McDougal*, George E. Killgore*, Uri A. Lopatin#, Rebecca Coffman**, J. Kathryn MacDonald††, Sigrid K. McAllister*, Gregory E. Fosheim*, Jean B. Patel*, and L. Clifford McDonald*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; ‡University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas, USA; §Saint Louis University School of Medicine, Saint Louis, Missouri, USA; ¶Michigan Department of Community Health, Lansing, Michigan, USA; #National Institutes of Health, Bethesda, Maryland, USA; **Oklahoma State Department of Health, Oklahoma City, Oklahoma, USA; ††Washington State Department of Health, Shoreline, Washington, USA
Main Article
Table 2
Outcomes of cases of Staphylococcus aureus community-acquired pneumonia associated with influenzalike illness, influenza season 2003–04
| Outcome |
No. (%), N = 17 |
| Hospitalization |
16 (94)* |
| Admitted to ICU† |
13 (81) |
| Required intubation |
8 (62) |
| Chest tube placement |
6 (46) |
| Median length of stay (range) |
13 days (1–108) |
| Death |
5 (29) |
| Median age, y |
28 (2–53) |
| Symptom onset to death, median days (range) |
7 (3–73) |
| Underlying disease |
1/5 (20)‡ |
Main Article
Top of Page